Kodi “Oyera” amatanthauza chiyani?
Nyamayo simanyamula masinthidwewo. Sichidzakhala matenda ndipo sadzaupereka.
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test for CNM is essential for responsible breeding, helping to identify carriers and reduce the risk of this debilitating condition. This simple yet effective test enables dog owners and breeders to make informed decisions, ensuring healthier puppies. By understanding the genetic predisposition to CNM, owners can provide better care and management for affected dogs. Regular screening through DNA testing not only promotes the health of individual dogs but also contributes to the overall well-being of the Border Collie breed. Invest in a CNM DNA test today to safeguard your canine companion’s future.
Centronuclear Myopathy (CNM) is a genetic disorder affecting Border Collies, characterized by muscle weakness and exercise intolerance. A DNA test can identify carriers and affected dogs, enabling breeders to make informed decisions to reduce the prevalence of this condition. Early detection through genetic testing can help owners manage symptoms and improve the quality of life for affected pets. Responsible breeding practices based on test results play a crucial role in preserving the health of the breed. Overall, DNA testing for CNM enhances breed welfare and promotes healthier generations of Border Collies.
Mayeso a DNA awa akuphatikizidwa kuyambira paketi yathu Basic - komanso ndi gawo la mapaketi Basic, Standard, Advanced, Complete.
Onani mapaketi a DNA Test →Centronuclear Myopathy (CNM) is a hereditary muscle disorder found in Border Collies. Characterized by weakness and muscle atrophy, this genetic condition significantly affects the dog's motor capabilities and overall quality of life. CNM results from mutations in specific genes leading to improper muscle fiber development and function.
Dogs affected by CNM typically exhibit clinical signs from a young age. Common symptoms include muscle weakness, reduced physical activity, exercise intolerance, abnormal gait, and muscle wasting. Severely affected dogs may have difficulty standing or walking, potentially impacting their ability to perform routine daily activities.
CNM in Border Collies is inherited in an autosomal recessive manner. This means a dog must inherit two copies of the mutated gene—one from each parent—to exhibit symptoms. Dogs carrying only one copy of the mutation (carriers) do not typically show signs but can pass the mutation onto offspring.
DNA testing is essential for identifying the CNM mutation in Border Collies. Early identification of affected and carrier dogs helps breeders make informed decisions, preventing the spread of the condition. DNA testing enables responsible breeding practices, assisting in reducing and eventually eliminating the occurrence of this debilitating condition.
The DNA test clearly distinguishes three genetic statuses:
Breeders are advised to conduct CNM DNA testing in breeding dogs before mating. Clear mating strategies should be selected to avoid producing affected puppies. Owners of Border Collies should consult veterinarians and genetic specialists for guidance on managing dogs diagnosed with CNM, ensuring the best possible quality of life.
Nyamayo simanyamula masinthidwewo. Sichidzakhala matenda ndipo sadzaupereka.
Ayi. Nyama nthawi zambiri imakhala yathanzi koma imatha kupatsira masinthidwe ake ana.
Imanyamula makope awiri osinthidwa. Zizindikiro zachipatala zimayembekezeredwa kutengera matenda. Siyenera kuŵetedwa.
Matenda ena ndi okhudzana ndi kugonana, kotero kuti maonekedwe awo amasiyana malingana ndi matenda kugonana kwa nyama.
This DNA test detects the mutation associated with Centronuclear Myopathy In Border Collie (CNM) in order to identify clear, carrier, or at-risk animals.
Kuyezetsa kwa DNA kumathandiza obereketsa kukonzekera zobereketsa zotetezeka komanso kuchepetsa chiopsezo chofalitsa masinthidwe kwa ana.
Njira yolandira cholowa yomwe idanenedwa pamayesowa ndi Autosomal Recessive.
This test analyses the mutation DNM2 c.1393C>T.
Osati kwenikweni. Kutanthauzira kumadalira mtundu wa cholowa ndi zotsatira zake.
Böhm Johann, Barthélémy Inès, Landwerlin Charlène, BlanchardGutton Nicolas, Relaix Frédéric, Blot Stéphane, Laporte Jocelyn, Tiret Laurent. A dog model for centronuclear myopathy carrying the most common DNM2 mutation. Dis Model Mech. 2022 Apr 1;15(4):dmm049219. doi: 10.1242/dmm.049219. Epub 2022 Apr 14.
Zinsinsi zanu, kusankha kwanu
Timagwiritsa ntchito makeke ofunikira kuti tiyendetse tsambalo. Ma cookie osasankha (monga ophatikizidwira) amayimitsidwa mwachisawawa ndipo amayatsidwa ngati mukuvomereza. Mutha kusintha zomwe mwasankha nthawi iliyonse pogwiritsa ntchito batani la "Cookies".
Zofunikira pazofunikira komanso chitetezo. Woyatsa nthawi zonse.
Imawongolera zinthu monga kusunga zokonda kapena zoyika zosatsatsa.
Imatithandiza kumvetsetsa kagwiritsidwe ntchito ka tsamba. Zayimitsidwa mwachisawawa.
Kutsatsa/kutsata mawebusayiti (makanema/mamapu ena). Zayimitsidwa mwachisawawa.